← All Sponsors
SPONSOR

Huihua Xiong

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: TNBC - Triple-Negative Breast Cancer
NCT06125080 Phase 2
Recruiting

The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospective, Open Clinical Study

TNBC - Triple-Negative Breast Cancer
China View Trial →